Genome-Wide Association Analysis for Severity of Coronary Artery Disease Using the Gensini Scoring System
Standard
Genome-Wide Association Analysis for Severity of Coronary Artery Disease Using the Gensini Scoring System. / Zeller, Tanja; Seiffert, Moritz; Müller, Christian; Scholz, Markus; Schäffer, Anna; Ojeda, Francisco; Drexel, Heinz; Mündlein, Axel; Kleber, Marcus E; März, Winfried; Sinning, Christoph; Brunner, Fabian J; Waldeyer, Christoph; Keller, Till; Saely, Christoph H; Sydow, Karsten; Thiery, Joachim; Teupser, Daniel; Blankenberg, Stefan; Schnabel, Renate.
in: FRONT CARDIOVASC MED, Jahrgang 4, 2017, S. 57.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Genome-Wide Association Analysis for Severity of Coronary Artery Disease Using the Gensini Scoring System
AU - Zeller, Tanja
AU - Seiffert, Moritz
AU - Müller, Christian
AU - Scholz, Markus
AU - Schäffer, Anna
AU - Ojeda, Francisco
AU - Drexel, Heinz
AU - Mündlein, Axel
AU - Kleber, Marcus E
AU - März, Winfried
AU - Sinning, Christoph
AU - Brunner, Fabian J
AU - Waldeyer, Christoph
AU - Keller, Till
AU - Saely, Christoph H
AU - Sydow, Karsten
AU - Thiery, Joachim
AU - Teupser, Daniel
AU - Blankenberg, Stefan
AU - Schnabel, Renate
PY - 2017
Y1 - 2017
N2 - Coronary artery disease (CAD) has a complex etiology involving numerous environmental and genetic factors of disease risk. To date, the genetic 9p21 locus represents the most robust genetic finding for prevalent and incident CAD. However, limited information is available on the genetic background of the severity and distribution of CAD. CAD manifests itself as stable CAD or acute coronary syndrome. The Gensini score quantifies the extent CAD but requires coronary angiography. Here, we aimed to identify novel genetic variants associated with Gensini score severity and distribution of CAD. A two-stage approach including a discovery and a replication stage was used to assess genetic variants. In the discovery phase, a meta-analysis of genome-wide association data of 4,930 CAD-subjects assessed by the Gensini score was performed. Selected single nucleotide polymorphisms (SNPs) were replicated in 2,283 CAD-subjects by de novo genotyping. We identified genetic loci located on chromosome 2 and 9 to be associated with Gensini score severity and distribution of CAD in the discovery stage. Although the loci on chromosome 2 could not be replicated in the second stage, the known CAD-locus on chromosome 9p21, represented by rs133349, was identified and, thus, was confirmed as risk locus for CAD severity.
AB - Coronary artery disease (CAD) has a complex etiology involving numerous environmental and genetic factors of disease risk. To date, the genetic 9p21 locus represents the most robust genetic finding for prevalent and incident CAD. However, limited information is available on the genetic background of the severity and distribution of CAD. CAD manifests itself as stable CAD or acute coronary syndrome. The Gensini score quantifies the extent CAD but requires coronary angiography. Here, we aimed to identify novel genetic variants associated with Gensini score severity and distribution of CAD. A two-stage approach including a discovery and a replication stage was used to assess genetic variants. In the discovery phase, a meta-analysis of genome-wide association data of 4,930 CAD-subjects assessed by the Gensini score was performed. Selected single nucleotide polymorphisms (SNPs) were replicated in 2,283 CAD-subjects by de novo genotyping. We identified genetic loci located on chromosome 2 and 9 to be associated with Gensini score severity and distribution of CAD in the discovery stage. Although the loci on chromosome 2 could not be replicated in the second stage, the known CAD-locus on chromosome 9p21, represented by rs133349, was identified and, thus, was confirmed as risk locus for CAD severity.
U2 - 10.3389/fcvm.2017.00057
DO - 10.3389/fcvm.2017.00057
M3 - SCORING: Journal article
C2 - 28979897
VL - 4
SP - 57
JO - FRONT CARDIOVASC MED
JF - FRONT CARDIOVASC MED
SN - 2297-055X
ER -